(Q33420546)

English

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

object named as

Susan L Cohn

10

0 references

Daphne Haas-Kogan

4

object named as

Daphne A Haas-Kogan

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Katherine K Matthay

22

object named as

Katherine K Matthay

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Steven G DuBois

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Susan Groshen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Julie R Park

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Xiaodong Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ethan Geier

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eugene Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathy Giacomini

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Brian Weiss

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Meaghan Granger

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gregory A Yanik

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Randall Hawkins

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jesse Courtier

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hollie Jackson

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fariba Goodarzian

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroyuki Shimada

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Scarlett Czarnecki

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Denice Tsao-Wei

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Judith G Villablanca

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Araz Marachelian

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

18 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2715-2721

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

28 July 2018

Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Inhibition of histone deacetylation: a strategy for tumor radiosensitization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470833

31 October 2018

Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25695691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25695691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25695691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/25695691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25695691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-14-3240

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33420546&oldid=1990379455"